Efficacy and Safety of 3‐Year Denosumab Therapy for Osteoporosis in Patients With Autoimmune Liver Diseases

Detalles Bibliográficos
Autores principales: Arase, Yoshitaka, Tsuruya, Kota, Hirose, Shunji, Ogiwara, Naoki, Yokota, Masashi, Anzai, Kazuya, Deguchi, Ryuzo, Shiraishi, Koichi, Shirai, Takayuki, Kagawa, Tatehiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Observations in Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028030/
https://www.ncbi.nlm.nih.gov/pubmed/31429969
http://dx.doi.org/10.1002/hep.30904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028030/
https://www.ncbi.nlm.nih.gov/pubmed/31429969
http://dx.doi.org/10.1002/hep.30904

Ejemplares similares